Neurocrine Biosciences
NBIX
#1391
Rank
$12.70 B
Marketcap
$125.51
Share price
-1.18%
Change (1 day)
13.84%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of September 2024 : $2.71 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company has $2.71 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$2.23 B30.69%
2022-12-31$$1.70 B24.29%
2021-12-31$$1.37 B22%
2020-12-31$$1.12 B76.83%
2019-12-31$$0.63 B32.48%
2018-12-31$$0.48 B29.19%
2017-12-31$$0.37 B18.19%
2016-12-31$$0.31 B-25.82%
2015-12-31$$0.42 B103.38%
2014-12-31$$0.20 B73.32%
2013-12-31$$0.12 B-22%
2012-12-31$$0.15 B156.94%
2011-12-31$$60.08 M210.58%
2010-12-31$$19.34 M389.25%
2009-12-31$$3.95 M-89.25%
2008-12-31$$36.77 M-69.02%
2007-12-31$$0.11 B-62.28%
2006-12-31$$0.31 B-19.33%
2005-12-31$$0.39 B-0.95%
2004-12-31$$0.39 B0.69%
2003-12-31$$0.39 B74.41%
2002-12-31$$0.22 B-27.75%
2001-12-31$$0.31 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$1.98 B-26.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.25 B 277.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.12 Million-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.32 B 426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.07 B 123.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$92.55 B 3,304.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.48 B-82.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-$36.4 Million-101.34%๐Ÿ‡บ๐Ÿ‡ธ USA